4.5. Drugs used in the treatment of obesity
4.5.1. Anti-obesity drugs acting on the gastro-intestinal tract
Restrictions: Restricted to use for patients with BMI >30 with relevant co-morbidities and BMI >35 without co-morbidities. Other conditions for prescribing should be in accordance with the Glasgow and Clyde Weight Management Service protocol. It should be prescribed only on the advice of the Glasgow and Clyde Weight Management Service.